An expert panel formed by the U.S. Food and Drug Administration has endorsed asbestos testing standards for cosmetics that reject long-held industry positions and reflect those of public health authorities and experts for thousands of plaintiffs who allege contaminated talc …
A study of more than 250,000 women found that those who used talc or other personal-hygiene powders weren’t significantly more likely to develop ovarian cancer, news that will impact thousands of legal claims against drugmaker Johnson & Johnson over the …
Johnson & Johnson agreed in the middle of a trial to pay more than $2 million to resolve a woman’s claims that asbestos-laced baby powder caused her cancer, according to people familiar with the case. The settlement marks a rare …
Johnson & Johnson Chief Executive Officer Alex Gorsky has declined to appear at a U.S. congressional hearing set for Tuesday on the safety of the company’s Baby Powder and other talc-based cosmetics. In an announcement, the House of Representatives Subcommittee …
At an invitation-only gathering late last year, U.S. regulators and their guests huddled at a hotel near Washington, D.C., to discuss the best way to detect cancer-causing asbestos in talc powders and cosmetics. The “Asbestos in Talc Symposium,” sponsored by …
As retailers pull Johnson & Johnson’s recalled talc-based baby powder from their shelves over reports of asbestos contamination, one competitor has yanked the mineral from its product altogether. Bausch Health Cos. Inc., maker of Shower to Shower powder, said it …
Johnson & Johnson said on Tuesday that 15 new tests found no asbestos in a bottle of baby powder that the U.S. Food and Drug Administration says tested positive for trace amounts of asbestos, a finding the agency stands by. …
Johnson & Johnson is recalling one lot of its Johnson’s Baby Powder after tiny amounts of asbestos contamination were found in samples from a single bottle purchased online. J&J is voluntarily recalling the lot, #22318RB, and encouraging people who bought …
Johnson & Johnson has taken some costly beatings in court this year. And it could get worse. Just last week, a jury ordered J&J to pay $8 billion for wrongfully pushing doctors to prescribe the anti-psychotic drug Risperdal. While the …
Johnson & Johnson wants its day in court to fight a lawsuit intended to force it to put a cancer warning on the company’s Baby Powder. So, it’s urging a judge not to let a law firm that’s been arguing …